Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 59, 1999 - Issue 5
Submit an article Journal homepage
50
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Determination of coagulation factor VIII activity by a chromogenic substrate method on STA, an automated coagulation analyzer

H A Kleinveld Department of Clinical Chemistry and Hematology, Atrium Medical Center, Heerlen, The Netherlands
,
N-E Andersson Chromogenix AB, Moe lndal, Sweden
,
H van Voorthuizen Nodia BV, Amsterdam, The Netherlands; and
,
J den Hartog Central Diagnostics Laboratory, University Hospital, Utrecht, The Netherlands
&
P G de Groot Central Diagnostics Laboratory, University Hospital, Utrecht, The Netherlands
Pages 335-341 | Published online: 08 Jul 2009

REFERENCES

  • Roberts RR. Hoffman M. Hemophilia and related conditions. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, editors. Williams hematology. New York: McGraw-Hill, 1995: 1413–39.
  • Rosen S, Andersson M, Blomback M, Hagglund U, Larrieu MJ, Wolf M, et al. Clinical application of a chromogenic substrate method determination of factor VIII activity. Thromb Haemost 1985; 54: 818–23.
  • Mertens K, van Wijngaarden A, Bertina RM. The role of factor VIII in the activation of blood coagulation factor X by activated factor IX. Thromb Haemost 1985; 54: 654–60.
  • Roddie PH, Ludlam CA. Recombinant coagula-tion factors. Blood Rev 1997; 11: 169–77.
  • Pasi KJ. Previously untreated patients and recom-binant factor VIII concentrate studies. Blood Coagul Fibrinolysis 1997; 8: S29–32.
  • Hellstern P, Faller B, Haas FJLM, van Sterkenburg B, Speiser W, Handler S, et al. Multicenter evaluation of the STA analyzer. Klin Lab 1994; 40: 509–22.
  • Barrowcliffe TW. Clotting factor concentrates in clinical practice. Standardization and assay. Semin Thromb Hemost 1993; 19: 73–9.
  • Dawson NJ, Kemball-Cook G, Barrowcliffe TW. Assay discrepancies with highly purified factor VIII concentrates. Haemostasis 1989; 19: 131–7.
  • Kasper CK, Aronson DL, Davignon G, Foster P, Hillman-Wiseman C, Lusher JM, et al. Compar-ison of six commercial plasma references for factor VIII, factor IX and von Willebrand factor. Thromb Haemost 1998; 74: 987–9.
  • Duncan EM, Duncan BM, Tunbridge LJ, Lloyd JV. Familial discrepancy between the one-stage and two-stage factor VIII methods in a subgroup of patients with haemofilia A. Br J Haematol 1994; 87: 846–8.
  • Rudzki Z, Duncan EM, Casey GJ, Neumann M, Favaloro EJ, Lloyd JV. Mutations in a subgroup of patients with mild haemophilia A and a familial discrepancy between the one-stage and two-stage factor VIII: C methods. Br J Haematol 1996; 94: 400–6.
  • Lee C, Barrowcliffe T, Bray G, Gomperts E, Hubbard A, Kemball-Cook G. Pharmacokinetic in vivo comparison using 1-stage and chromogenic substrate assays with two formulations of Hemofil-M. Thromb Haemost 1996; 76: 950–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.